31. Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer. (3rd August 2019) Authors: Ingles Garces, Alvaro H; Au, Lewis; Mason, Robert; Thomas, Jennifer; Larkin, James Journal: Expert opinion on investigational drugs Issue: Volume 28:Number 8(2019) Page Start: 695 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Checkpoint Inhibitor-associated Cutaneous Small Vessel Vasculitis: A Review of the Literature. Issue 3 (14th April 2021) Authors: Ho, Bernard; Larkin, James; Heelan, Kara Journal: Journal of immunotherapy Issue: Volume 44:Issue 3(2021) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Checkpoint Inhibitor-associated Cutaneous Small Vessel Vasculitis: A Review of the Literature. Issue 3 (April 2021) Authors: Ho, Bernard; Larkin, James; Heelan, Kara Journal: Journal of immunotherapy Issue: Volume 44:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Checkpoint inhibitor‐associated bullous cutaneous immune‐related adverse events: a multicentre observational study. (1st December 2022) Authors: Kawsar, Anusuya; Edwards, Charlotte; Patel, Pooja; Heywood, Richard M.; Gupta, Aakriti; Mann, Jasmine; Harland, Christopher; Heelan, Kara; Larkin, James; Lorigan, Paul; Harwood, Catherine A.; Matin, Rubeta N.; Fearfield, Louise Journal: British journal of dermatology Issue: Volume 187:Number 6(2022) Page Start: 981 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Checkpoint inhibitor‐associated bullous cutaneous immune‐related adverse events: a multicentre observational study. (6th September 2022) Authors: Kawsar, Anusuya; Edwards, Charlotte; Patel, Pooja; Heywood, Richard M.; Gupta, Aakriti; Mann, Jasmine; Harland, Christopher; Heelan, Kara; Larkin, James; Lorigan, Paul; Harwood, Catherine A.; Matin, Rubeta N.; Fearfield, Louise Journal: British journal of dermatology Issue: Volume 187:Number 6(2022) Page Start: 981 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Clinical Models to Define Response and Survival With Anti–PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma. Issue 10 (1st April 2022) Authors: Pires da Silva, Inês; Ahmed, Tasnia; McQuade, Jennifer L.; Nebhan, Caroline A.; Park, John J.; Versluis, Judith M.; Serra-Bellver, Patricio; Khan, Yasir; Slattery, Tim; Oberoi, Honey K.; Ugurel, Selma; Haydu, Lauren E.; Herbst, Rudolf; Utikal, Jochen; Pföhler, Claudia; Terheyden, Patrick; Weichen... Journal: Journal of clinical oncology Issue: Volume 40:Issue 10(2022) Page Start: 1068 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab. Issue 7 (7th July 2021) Authors: Alexander, James L; Ibraheim, Hajir; Sheth, Bhavisha; Little, Jessica; Khan, Muhammad Saheb; Richards, Camellia; Hunter, Nikki; Chauhan, Dharmisha; Ratnakumaran, Raguprakash; McHugh, Kathleen; Pinato, David J; Nathan, Paul; Choy, Julia; Crusz, Shanthini M; Furness, Andrew; Turajlic, Samra; Picker... Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial. Issue 9 (September 2016) Authors: Ascierto, Paolo A; McArthur, Grant A; Dréno, Brigitte; Atkinson, Victoria; Liszkay, Gabrielle; Di Giacomo, Anna Maria; Mandalà, Mario; Demidov, Lev; Stroyakovskiy, Daniil; Thomas, Luc; de la Cruz-Merino, Luis; Dutriaux, Caroline; Garbe, Claus; Yan, Yibing; Wongchenko, Matthew; Chang, Ilsung; Hsu,... Journal: Lancet oncology Issue: Volume 17:Issue 9(2016:Sep.) Page Start: 1248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. Combination dabrafenib and trametinib in the management of advanced melanoma with BRAFV600 mutations. (2nd May 2016) Authors: Spain, Lavinia; Julve, Maximilian; Larkin, James Journal: Expert opinion on pharmacotherapy Issue: Volume 17:Number 7(2016) Page Start: 1031 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Combination immune checkpoint blockade with ipilimumab and nivolumab in the management of advanced melanoma. (3rd March 2016) Authors: Spain, Lavinia; Larkin, James Journal: Expert opinion on biological therapy Issue: Volume 16:Number 3(2016:Mar.) Page Start: 389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗